GURUFOCUS.COM » STOCK LIST » Basic Materials » Chemicals » Novonesis AS (OTCPK:NVZMY) » Definitions » Cyclically Adjusted Revenue per Share

Novonesis AS (Novonesis AS) Cyclically Adjusted Revenue per Share : $8.38 (As of Dec. 2023)


View and export this data going back to 2009. Start your Free Trial

What is Novonesis AS Cyclically Adjusted Revenue per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Novonesis AS's adjusted revenue per share for the three months ended in Dec. 2023 was $2.419. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is $8.38 for the trailing ten years ended in Dec. 2023.

During the past 12 months, Novonesis AS's average Cyclically Adjusted Revenue Growth Rate was 4.50% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was 8.20% per year. During the past 5 years, the average Cyclically Adjusted Revenue Growth Rate was 7.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of Novonesis AS was 8.20% per year. The lowest was 4.40% per year. And the median was 6.95% per year.

As of today (2024-04-27), Novonesis AS's current stock price is $55.76. Novonesis AS's Cyclically Adjusted Revenue per Share for the quarter that ended in Dec. 2023 was $8.38. Novonesis AS's Cyclically Adjusted PS Ratio of today is 6.65.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Novonesis AS was 11.43. The lowest was 5.01. And the median was 7.87.


Novonesis AS Cyclically Adjusted Revenue per Share Historical Data

The historical data trend for Novonesis AS's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Novonesis AS Cyclically Adjusted Revenue per Share Chart

Novonesis AS Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 6.42 7.30 7.40 7.78 8.38

Novonesis AS Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 7.78 8.08 8.12 7.97 8.38

Competitive Comparison of Novonesis AS's Cyclically Adjusted Revenue per Share

For the Specialty Chemicals subindustry, Novonesis AS's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Novonesis AS's Cyclically Adjusted PS Ratio Distribution in the Chemicals Industry

For the Chemicals industry and Basic Materials sector, Novonesis AS's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Novonesis AS's Cyclically Adjusted PS Ratio falls into.



Novonesis AS Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Novonesis AS's adjusted Revenue per Share data for the three months ended in Dec. 2023 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=2.419/116.7000*116.7000
=2.419

Current CPI (Dec. 2023) = 116.7000.

Novonesis AS Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201403 1.767 99.600 2.070
201406 1.764 99.700 2.065
201409 1.755 99.700 2.054
201412 1.691 99.400 1.985
201503 1.669 100.200 1.944
201506 1.671 100.300 1.944
201509 1.716 100.200 1.999
201512 1.640 99.800 1.918
201603 1.761 100.200 2.051
201606 1.701 100.600 1.973
201609 1.689 100.200 1.967
201612 1.758 100.300 2.045
201703 1.798 101.200 2.073
201706 1.793 101.200 2.068
201709 1.935 101.800 2.218
201712 1.977 101.300 2.278
201803 1.976 101.700 2.267
201806 1.872 102.300 2.136
201809 1.960 102.400 2.234
201812 1.954 102.100 2.233
201903 1.825 102.900 2.070
201906 1.815 102.900 2.058
201909 1.913 102.900 2.170
201912 1.958 102.900 2.221
202003 1.975 103.300 2.231
202006 1.790 103.200 2.024
202009 1.931 103.500 2.177
202012 2.006 103.400 2.264
202103 2.151 104.300 2.407
202106 2.066 105.000 2.296
202109 2.127 105.800 2.346
202112 2.083 106.600 2.280
202203 2.316 109.900 2.459
202206 2.179 113.600 2.238
202209 2.087 116.400 2.092
202212 2.320 115.900 2.336
202303 2.394 117.300 2.382
202306 2.208 116.400 2.214
202309 2.296 117.400 2.282
202312 2.419 116.700 2.419

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.


Novonesis AS  (OTCPK:NVZMY) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Novonesis AS's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=55.76/8.38
=6.65

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Novonesis AS was 11.43. The lowest was 5.01. And the median was 7.87.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Novonesis AS Cyclically Adjusted Revenue per Share Related Terms

Thank you for viewing the detailed overview of Novonesis AS's Cyclically Adjusted Revenue per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Novonesis AS (Novonesis AS) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Basic Materials » Chemicals » Novonesis AS (OTCPK:NVZMY) » Definitions » Cyclically Adjusted Revenue per Share
Address
Krogshoejvej 36, Bagsvaerd, DNK, 2880
Novozymes is the world leader in industrial enzymes. In recent years, the company has expanded into micro-organisms, primarily for agricultural markets. The firm supplies five major industry groups: household care, food and beverages, bioenergy, agriculture and feed, and technical and pharma. Its biological solutions create value for its customers by improving yield efficiency and performance, while saving energy and generating less waste. The company is headquartered in Denmark.

Novonesis AS (Novonesis AS) Headlines

From GuruFocus

Novozymes A/S's Dividend Analysis

By GuruFocus Research 10-19-2023

2 Holdings to Reduce Based on Analyst Recommendations

By Alberto Abaterusso Alberto Abaterusso 11-06-2019

Not Just Yogurt Anymore

By PRNewswire 10-26-2023